Christophe Weber is next in line for the throne at Takeda, and the former GlaxoSmithKline exec has a mind to grow the Japanese pharma through dealmaking, hoping to refill the in-transition company’s pipeline and expand in emerging markets.

…read more

Source: Takeda’s chief-in-waiting sees big M&A in the drugmaker’s future


0 No comments